Key statistics
On Friday, Herantis Pharma Oyj (HRTIS:HEX) closed at 1.98, 65.00% above the 52 week low of 1.20 set on Apr 07, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 1.99 |
|---|---|
| High | 2.18 |
| Low | 1.95 |
| Bid | -- |
| Offer | -- |
| Previous close | 1.95 |
| Average volume | 40.74k |
|---|---|
| Shares outstanding | 24.09m |
| Free float | 18.30m |
| P/E (TTM) | -- |
| Market cap | 47.71m EUR |
| EPS (TTM) | -0.2417 EUR |
Data delayed at least 15 minutes, as of Feb 13 2026 17:00 GMT.
More ▼
Announcements
- Herantis Pharma - Phase 1b biomarker data show clear evidence of biological response to HER-096 in people with Parkinson's disease
- Herantis Pharma presents positive topline data for HER-096 in Phase 1b trial for people living with Parkinson’s disease
- Last patient visit completed on schedule in Phase 1b clinical trial of HER-096 for Parkinson’s disease
- First patients dosed in final cohort of Phase 1b clinical trial of HER-096 for Parkinson’s disease
